Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ClearCardio is a medical technology company specializing in advanced cardiovascular imaging and diagnostic solutions. The company leverages artificial intelligence and machine learning to provide non-invasive, high-resolution analysis of coronary artery disease, aiming to improve the accuracy of cardiac risk assessments. Their primary product suite focuses on enhancing the interpretation of Coronary Computed Tomography Angiography (CCTA) to identify vulnerable plaques and quantify arterial stenosis. By providing clinicians with actionable insights, ClearCardio seeks to reduce the incidence of heart attacks and optimize patient management strategies in cardiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ClearCardio.